摘要
目的通过检测癌基因Bmi-1在卵巢上皮癌中表达情况,探讨其与端粒酶活性的关系。方法①使用Reahime—PCR的方法检测47例卵巢上皮癌组织中Bmi-1基因的mRNA表达情况;②采用免疫组化SP法检测47例卵巢上皮癌组织中Bmi-1蛋白的表达;③改良端粒重复序列扩增技术(telomerase repeat amplification protocol)——TRAP-银染技术检测该47例卵巢上皮癌组织中端粒酶基因水平;④Western Blot检测卵巢上皮癌组织中端粒酶蛋白表达量。结果①Bmi-1蛋白在卵巢上皮癌组织中较正常组织有明显表达(P〈0.05),并且与病理分级和临床分期有关,G3级阳性表达率(93.10%)高于G2级(61.11%),Ⅱ期、Ⅲ期阳性表达率(66.67%)低于Ⅳ期(92.31%),二者均有统计学差异(P〈0.05)。②卵巢上皮癌组织中端粒酶活性阳性检测率为87.23%(41/47),正常组织中阴性表达;③端粒酶活性阳性标本中Bmi-1蛋白高表达,占90.24%,spearman相关性分析显示Bmi-1蛋白表达与端粒酶活性阳性率呈正相关(P〈0.05)。结论Bmi-1基因和蛋白在卵巢上皮癌组织中高表达,其表达率与组织学分级和临床期别相关;Bmi-1阳性率与端粒酶活性阳性率密切相关,其在卵巢癌的发病过程中可能有重要意义.值得进一步研究。
Objective To detect the correlation between the expression of oncogene Bmi-1 gene and telomerase activity in ovarian cancer. Methods RT-PCR method and SP immunohistochemistry were adopted to detect the mRNA of Bmi-1 gene and the expression of Bmi-1 protein in tissues of 47 ovarian epithelial cancer cases. TRAP-silver staining technique was used to detect the telomerase activity. Western Blot was adopted to detect the expression of Telomerase hTERT. Results Compared with the normal ovary epithelium tissues, Bmi-1 protein in tissues of 47 ovarian epithelial cancer cases processed more obvious expression and was related to pathological grade and clinical stage. Significant Bmi-1 expression levels were found among different clinopathological types of the cancer ( P 〈 0.05 ). In ovarian epithelial cancer tissues, 87.23% demonstrated positive telomerase activity in contrast to zero activity in normal tissues. Majority (90.24%) of specimens with positive telomerase activity possessed high Bmi-1 expression levels. Spearman correlation analysis indicated that expression of Bmi- 1 protein was positively correlated with the elevated telomerase activity. Conclusion Bmi-1 protein is highly expressed in ovarian epithelial cancer tissues, and its expression level correlates with histological grade and clinical phase of the patients. Elevation of Bmi-1 expression is closely correlated to the increased telomerase activity, and plays a significant role in the pathogenesis of Ovarian Cancer, which deserves further researches.
出处
《国际免疫学杂志》
CAS
北大核心
2009年第6期421-425,共5页
International Journal of Immunology
关键词
BMI-1
端粒酶
卵巢癌
Key words Bmi-1
Telomerase
Ovarian cancer